Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 26, 2021

SELL
$41.02 - $58.65 $270,773 - $387,148
-6,601 Closed
0 $0
Q2 2021

Jul 27, 2021

BUY
$43.76 - $53.11 $11,290 - $13,702
258 Added 4.07%
6,601 $291,000
Q4 2020

Jan 29, 2021

SELL
$41.16 - $47.47 $4,116 - $4,747
-100 Reduced 1.55%
6,343 $267,000
Q3 2020

Nov 10, 2020

SELL
$43.36 - $53.53 $116,464 - $143,781
-2,686 Reduced 29.42%
6,443 $295,000
Q2 2020

Aug 07, 2020

SELL
$46.37 - $57.58 $138,739 - $172,279
-2,992 Reduced 24.68%
9,129 $458,000
Q1 2020

Apr 28, 2020

BUY
$40.22 - $62.0 $1,166 - $1,798
29 Added 0.24%
12,121 $623,000
Q2 2019

Jul 30, 2019

SELL
$81.3 - $97.35 $16,016 - $19,177
-197 Reduced 1.6%
12,092 $1.02 Million
Q1 2019

Apr 22, 2019

BUY
$69.08 - $105.66 $5,181 - $7,924
75 Added 0.61%
12,289 $1.17 Million
Q3 2018

Oct 24, 2018

SELL
$85.46 - $126.37 $211,000 - $312,007
-2,469 Reduced 16.82%
12,214 $1.04 Million
Q2 2018

Jul 09, 2018

SELL
$81.85 - $120.51 $410,395 - $604,237
-5,014 Reduced 25.46%
14,683 $1.7 Million
Q1 2018

May 11, 2018

SELL
$57.91 - $92.15 $495,941 - $789,172
-8,564 Reduced 30.3%
19,697 $1.59 Million
Q1 2018

Apr 19, 2018

BUY
$57.91 - $92.15 $1.64 Million - $2.6 Million
28,261 New
28,261 $2.29 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.